@article{fe06e65d2d6a47ec978a72216ce4f147,
title = "Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML",
author = "K. Takahashi and E. Jabbour and X. Wang and R. Luthra and C. Bueso-Ramos and K. Patel and S. Pierce and H. Yang and Y. Wei and N. Daver and S. Faderl and F. Ravandi and Z. Estrov and J. Cortes and H. Kantarjian and G. Garcia-Manero",
note = "Funding Information: This work was supported by the Ruth and Ken Arnold Fund, the Edward P Evans foundation (GGM and YW), the Celgene Future Leaders in Hematology Award, and Kimberly Patterson Leukemia Research Fellowship (KT). The authors would like to thank Professor Akifumi Takaori at Kyoto University for providing critical review and advice about the project.",
year = "2013",
month = oct,
doi = "10.1038/leu.2013.165",
language = "English (US)",
volume = "27",
pages = "2081--2083",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "10",
}